Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomasAna Guerreiro Stücklin, Nataliya Zhukova, Álvaro Lassaletta et al.|Nature Communications|2019Cited by 372
Predominant antitumor effects by fully human anti-TRAIL-receptor2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivoMotoo Nagane, Yoshiaki Shiokawa|Neuro-Oncology|2010Cited by 24